De Sadeleer C - Search Results

1

Optimizing background correction when calculating differential renal function in the presence of hydroureteronephrosis using 99Tc(m)-DTPA.

Van de Wiele C, De Sadeleer C, Koole M, D'Asseler Y, Everaert K, Dierckx RA. Van de Wiele C, et al. Among authors: de sadeleer c. Nucl Med Commun. 1998 Mar;19(3):251-5. doi: 10.1097/00006231-199803000-00009. Nucl Med Commun. 1998. PMID: 9625500

2

Estimation of risk based on biological dosimetry for patients treated with radioiodine.

Monsieurs MA, Thierens HM, van de Wiele CV, Vral AM, Meirlaen IA, de Winter HA, de Sadeleer CJ, de Ridder LI, Kaufman JM, Dierckx RA. Monsieurs MA, et al. Among authors: de ridder li, de sadeleer cj, de winter ha. Nucl Med Commun. 1999 Oct;20(10):911-7. doi: 10.1097/00006231-199910000-00008. Nucl Med Commun. 1999. PMID: 10528296 Clinical Trial.

3

The contribution of bone scintigraphy in occupational health or medical insurance claims: a retrospective study.

Versijpt J, Dierckx RA, De Bondt P, Dierckx I, Lambrecht L, De Sadeleer C. Versijpt J, et al. Among authors: de sadeleer c, de bondt p. Eur J Nucl Med. 1999 Aug;26(8):804-11. doi: 10.1007/s002590050452. Eur J Nucl Med. 1999. PMID: 10436191

4

Quantification of 99Tcm-HMPAO brain SPET in two series of healthy volunteers using different triple-headed SPET configurations: normal databases and methodological considerations.

Van Laere K, De Sadeleer C, Dobbeleir A, Bossuyt A, De Deyn P, Dierckx R. Van Laere K, et al. Among authors: de deyn p, de sadeleer c. Nucl Med Commun. 1999 Nov;20(11):1031-40. doi: 10.1097/00006231-199911000-00008. Nucl Med Commun. 1999. PMID: 10572913 Clinical Trial.

5

Tc-99m MDP uptake in herniated stomach tissue.

De Sadeleer C, Van de Wiele C, De Winter F, De Bondt P, Dierckx RA. De Sadeleer C, et al. Among authors: de winter f, de bondt p. Clin Nucl Med. 2000 May;25(5):386-7. doi: 10.1097/00003072-200005000-00021. Clin Nucl Med. 2000. PMID: 10795708 No abstract available.

6

Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.

Van Laere K, Casier K, Uyttendaele D, Mondelaers W, De Sadeleer C, Simons M, Dierckx R. Van Laere K, et al. Among authors: de sadeleer c. J Nucl Med. 1998 Sep;39(9):1563-9. J Nucl Med. 1998. PMID: 9744344 Free article.

7

Simplified algorithms for the estimation of 99Tcm-MAG3 clearance.

De Sadeleer C, Piepsz A, Tondeur M, Ham HR. De Sadeleer C, et al. Nucl Med Commun. 2000 Jan;21(1):65-9. doi: 10.1097/00006231-200001000-00011. Nucl Med Commun. 2000. PMID: 10717904

8

Which single blood sample method should be used to estimate 51Cr-EDTA clearance in adolescents?

Ham HR, De Sadeleer C, Hall M, Piepsz A. Ham HR, et al. Among authors: de sadeleer c. Nucl Med Commun. 2004 Feb;25(2):155-7. doi: 10.1097/00006231-200402000-00011. Nucl Med Commun. 2004. PMID: 15154705 Clinical Trial.

9

How good is technetium-99m mercaptoacetyltriglycine indirect cystography?

De Sadeleer C, De Boe V, Keuppens F, Desprechins B, Verboven M, Piepsz A. De Sadeleer C, et al. Among authors: de boe v. Eur J Nucl Med. 1994 Mar;21(3):223-7. doi: 10.1007/BF00188670. Eur J Nucl Med. 1994. PMID: 8200390

10

Renal technetium-99m-DMSA SPECT in normal volunteers.

De Sadeleer C, Bossuyt A, Goes E, Piepsz A. De Sadeleer C, et al. J Nucl Med. 1996 Aug;37(8):1346-9. J Nucl Med. 1996. PMID: 8708769 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters